This review offers a summary of the current knowledge of pshychotropic drugs and glaucoma. If exposed to psychotropic drugs, some patients may develop angle-closure glaucoma. Although rarely contraindicated, exposed predisposed and diagnosed patients should be followed-up by an ophthalmologist. It is still unclear if serotonin reuptake inhibitors increase the risk of angle-closure glaucoma. Tricyclic antidepressants and benzodiazepines should be used with caution in predisposed patients. The same applies to antipsychotic drugs, where first-generation antipsychotic drugs might have a smaller impact on the intraocular pressure than second-generation antipsychotic drugs.
|Bidragets oversatte titel
|Psychotropic drugs for patients with glaucoma
|Ugeskrift for Laeger
|Udgivet - 27 nov. 2023
Bibliografisk notePublished under Open Access CC-BY-NC-BD 4.0. https://creativecommons.org/licenses/by-nc-nd/4.0/.
- Antipsychotic Agents/adverse effects
- Glaucoma, Angle-Closure/chemically induced
- Glaucoma/chemically induced
- Psychotropic Drugs
- Selective Serotonin Reuptake Inhibitors/adverse effects